KDM3A and neoplasm: Downregulation of KDM3A in HCT116 CRC cells inhibits the clonogenic activity of CRC cells [42,45], arrests cell cycle progression, suppresses CRC cell proliferation and migration, and reduces xenograft tumor formation [26,27].